BLUE APRON HOLDINGS INC-A (APRN)

US09523Q3092 - Common Stock

12.99  -0.01 (-0.08%)

After market: 12.99 0 (0%)

Fundamental Rating

1

Overall APRN gets a fundamental rating of 1 out of 10. We evaluated APRN against 41 industry peers in the Consumer Staples Distribution & Retail industry. APRN has a bad profitability rating. Also its financial health evaluation is rather negative. APRN is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

APRN had negative earnings in the past year.
In the past year APRN has reported a negative cash flow from operations.
In the past 5 years APRN always reported negative net income.
In the past 5 years APRN always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -146.26%, APRN is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -146.26%
ROE N/A
ROIC N/A
ROA(3y)-41.24%
ROA(5y)-36.22%
ROE(3y)-169.36%
ROE(5y)-140.05%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of APRN (35.18%) is better than 86.36% of its industry peers.
APRN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for APRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.57%
GM growth 5Y3.16%

1

2. Health

2.1 Basic Checks

APRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, APRN has about the same amount of shares outstanding.
The number of shares outstanding for APRN has been reduced compared to 5 years ago.
APRN has a worse debt/assets ratio than last year.

2.2 Solvency

APRN has an Altman-Z score of -11.41. This is a bad value and indicates that APRN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.41, APRN is doing worse than 93.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.41
ROIC/WACCN/A
WACC11.65%

2.3 Liquidity

APRN has a Current Ratio of 0.66. This is a bad value and indicates that APRN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.66, APRN is not doing good in the industry: 88.64% of the companies in the same industry are doing better.
APRN has a Quick Ratio of 0.66. This is a bad value and indicates that APRN is not financially healthy enough and could expect problems in meeting its short term obligations.
APRN has a Quick ratio of 0.63. This is comparable to the rest of the industry: APRN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.63

2

3. Growth

3.1 Past

The earnings per share for APRN have decreased strongly by -16.20% in the last year.
APRN shows a decrease in Revenue. In the last year, the revenue decreased by -4.99%.
The Revenue for APRN have been decreasing by -12.25% on average. This is quite bad
EPS 1Y (TTM)-16.2%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-27.96%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y0.26%
Revenue growth 5Y-12.25%
Revenue growth Q2Q-14.49%

3.2 Future

The Earnings Per Share is expected to grow by 19.82% on average over the next years. This is quite good.
Based on estimates for the next years, APRN will show a small growth in Revenue. The Revenue will grow by 5.20% on average per year.
EPS Next Y54.45%
EPS Next 2Y37.61%
EPS Next 3Y26.25%
EPS Next 5Y19.82%
Revenue Next Year-8.95%
Revenue Next 2Y-1.64%
Revenue Next 3Y3.66%
Revenue Next 5Y5.2%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for APRN. In the last year negative earnings were reported.
Also next year APRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as APRN's earnings are expected to grow with 26.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.61%
EPS Next 3Y26.25%

0

5. Dividend

5.1 Amount

APRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE APRON HOLDINGS INC-A

NASDAQ:APRN (11/10/2023, 7:00:00 PM)

After market: 12.99 0 (0%)

12.99

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap83.53M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.26%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 35.18%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover5.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.66
Quick Ratio 0.63
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-16.2%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y54.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y0.26%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y